Dimenhydrinate 25 MG Chewable Tablet — RxCUI 1245184
RxNorm drug concept · Semantic clinical drug
RxCUI 1245184
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1245184
Official nameDimenhydrinate 25 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dimenhydrinate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Dimenhydrinate works by calming your inner ear when it gets overstimulated during travel — that's the root cause of the nausea, vomiting, and dizziness you feel. It's proven effect...
- What exactly does dimenhydrinate do — and will it stop my motion sickness?
- Drowsiness is the most common side effect — it's very real and something to plan for. Avoid driving or operating machinery until you know how dimenhydrinate affects you. Alcohol, s...
- It can be used in children as young as 2 years old — but only with a doctor's guidance for children under 2, and never in newborns. In young children especially, antihistamine over...
🕸️ Concept Web — How Dimenhydrinate 25 MG Chewable Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dimenhydrinate 25 MG Chewable Tablet
RxCUI 1245184 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Dimenhydrinate
3444IN
-
Dimenhydrinate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Dramamine
151666BN
-
Dramamine
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dimenhydrinate Chewable Tablet
371861SCDF -
Dimenhydrinate Chewable Product
1294911SCDG -
Dimenhydrinate Oral Product
1151896SCDG -
Dimenhydrinate Pill
1151897SCDG -
Dimenhydrinate Chewable Tablet [Dramamine]
602222SBDF -
Dramamine Chewable Product
1296525SBDG -
Dramamine Oral Product
1175934SBDG -
Dramamine Pill
1175935SBDG - +4 more in this family
-
Dimenhydrinate Chewable Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dimenhydrinate 25 MG
315829SCDC -
Dimenhydrinate 25 MG Chewable Tablet [Dramamine]
1245186SBD -
Dimenhydrinate 25 MG [Dramamine]
1245185SBDC
-
Dimenhydrinate 25 MG
Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dimenhydrinate 25 MG
SCDC · 315829 -
Dimenhydrinate Chewable Tablet
SCDF · 371861 -
Dimenhydrinate Chewable Product
SCDG · 1294911 -
Dimenhydrinate Oral Product
SCDG · 1151896 -
Dimenhydrinate Pill
SCDG · 1151897
Brand-Name Concepts
-
Dimenhydrinate 25 MG Chewable Tablet [Dramamine]
SBD · 1245186 -
Dimenhydrinate 25 MG [Dramamine]
SBDC · 1245185 -
Dimenhydrinate Chewable Tablet [Dramamine]
SBDF · 602222 -
Dramamine Chewable Product
SBDG · 1296525 -
Dramamine Oral Product
SBDG · 1175934 -
Dramamine Pill
SBDG · 1175935 -
Dramamine
BN · 151666
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 1245184 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 63029-0904-01 | 1 CASE in 1 BLISTER PACK (63029-904-01) / 8 TABLET, CHEWABL... | Dramamine for Kids | Medtech Products Inc. | 2012-02-15 |
| 63029-0908-08 | 1 BLISTER PACK in 1 BOX (63029-908-08) / 8 TABLET, CHEWABLE... | Dramamine for Kids | Medtech Products Inc. | 2025-02-17 |
| 63029-0910-01 | 1 BLISTER PACK in 1 CASE (63029-910-01) / 8 TABLET, CHEWABL... | Dramamine for Kids | Medtech Products Inc. | 2012-02-15 |
Observed labelers:
Medtech Products Inc. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.